Skip Navigation

Recalled LINX Device Caused Recurrence of GERD Symptoms, Requiring Surgical Removal: Lawsuit

Recalled LINX Device Caused Recurrence of GERD Symptoms, Requiring Surgical Removal

A Missouri man has filed a lawsuit claiming that he experienced nothing but problems with a LINX Reflux Management System, which provided few benefits, resulted in the return of his acid reflux and ultimately required additional medical procedures to remove the device after it failed inside his body.

The complaint (PDF) was brought by Deral Vincent in the U.S. District Court for the District of Minnesota on July 30. It names Torax Medical Inc. and Ethicon Inc. as defendants. Both companies are subsidiaries of Johnson & Johnson.

Vincent claims the defendants placed a defective medical device into the stream of commerce without adequately testing it or providing proper warnings about the potential problems users may experience.

LINX Reflux System Problems

The LINX system consists of a small ring of magnetic beads held together by titanium wires. It is surgically implanted around the lower esophageal sphincter to help strengthen it and prevent the backward flow of stomach acid due to conditions such as gastroesophageal reflux disease (GERD).

First approved in March 2012 by the U.S. Food and Drug Administration, the LINX system soon became associated with reports of failures, resulting in pieces of the broken implants migrating through patientsโ€™ bodies, puncturing organs and causing other health complications. The FDA announced a LINX recall in April 2018 after determining the problem was likely caused by a manufacturing error.

Vincentโ€™s complaint joins a number of similar LINX device lawsuits now being pursued in courts nationwide, each involving similar allegations that the implants were defectively designed and manufactured, placing patients at risk for the sake of the manufacturersโ€™ profits.

LINX-Reflux-Device-Lawsuit-Lawyer
LINX-Reflux-Device-Lawsuit-Lawyer

LINX Device Failure Allegations

Vincent indicates he was implanted with a LINX Reflux Management System on July 27, 2018, less than two months after Torax initiated a recall on May 31 involving an โ€œout of specification conditionโ€ that could allow a magnetic bead to separate from an adjacent wire link.

According to the complaint, Vincentโ€™s specific implant was among the recalled devices. The recall notice warned that separation could cause the LINX ring to become discontinuous or open, potentially resulting in the recurrence of GERD symptoms and the need for additional surgery to remove or replace the device.

Vincent claims that is ultimately what happened to him, resulting in a severe recurrence of his GERD symptoms. On April 3, 2025, nearly seven years after receiving the implant, he underwent another invasive surgery to remove the failed LINX system.

โ€œAs a result of Defendant Toraxโ€™s violations of federal regulation, approved manufacturing process, and manufacturing standard of care, Plaintiffโ€™s LINX was defectively manufactured and failed as a result of that defect. At the time the LINX device left the control of Defendant Torax, it was outside of manufacturing specification and was unreasonably dangerous due to its defective manufacture.โ€

Deral Vincent v. Torax Medical Inc. et al.

Vincent presents claims of manufacturing defect, negligence, negligence per se and strict liability. He is seeking compensatory damages.

LINX Implant Lawsuits

The complaint joins a growing number of similar LINX implant lawsuits filed in the District of Minnesota, where Torax Medical is headquartered and where the device was originally developed.

LINX implant lawyers expect the number of claims to continue to rise as more individuals currently implanted with the devices experience breakages, and as more patients discover that their LINX broke because of a manufacturing defect.

As a result, attorneys are actively reviewing potential LINX lawsuits for those seeking compensation after having suffered injuries or complications due to:

  • Device failures
  • Migration and organ punctures
  • Need for additional revision surgery to remove a failed device

Sign up for more legal news that could affect you or your family.

Irvin Jackson
Written By: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

C.R. Bard and its Becton Dickinson parent company face more than 3,700 Bard PowerPort lawsuits that claim the port catheters are defectively designed.
A Dupixent CTCL lawsuit indicates manufacturers have long known the eczema treatment was linked to an increased cancer risk, but failed to warn doctors or patients.
Manufacturer wants the Judicial Panel on Multidistrict Litigation to reject a proposal by a group of plaintiffs to consolidate all federal Abbott spinal cord stimulator lawsuits.